APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor Concentrates

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Coagulation Factor Concentrates Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchCoagulation Factor Concentrates Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor Concentrates Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor Concentrates Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor Concentrates Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Coagulation Factor Concentrates market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Coagulation Factor Concentrates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Coagulation Factor Concentrates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Coagulation Factor Concentrates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Coagulation Factor Concentrates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Coagulation Factor Concentrates include Bio Product Laboratory (UK), Biotest (Germany), CSL (Australia), Green Cross Corporation (South Korea), Grifols (Spain), Japan Blood Products Organization, China Biologic Products (China), Kedrion (Italy), LFB (France) and Octapharma (Switzerland), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Coagulation Factor Concentrates, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coagulation Factor Concentrates, also provides the sales of main regions and countries. Of the upcoming market potential for Coagulation Factor Concentrates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coagulation Factor Concentrates sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coagulation Factor Concentrates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Coagulation Factor Concentrates sales, projected growth trends, production technology, application and end-user industry.

Coagulation Factor Concentrates Segment by Company

Bio Product Laboratory (UK)

Biotest (Germany)

CSL (Australia)

Green Cross Corporation (South Korea)

Grifols (Spain)

Japan Blood Products Organization, China Biologic Products (China)

Kedrion (Italy)

LFB (France)

Octapharma (Switzerland)

Sanquin (Netherlands)

Shire (Ireland)

Shanghai RAAS Blood Products (China)

Coagulation Factor Concentrates Segment by Type

Factor XIII

Factor VIII

Factor IX

Fibrinogen Concentrates

Prothrombin Complex Concentrates

Von Willebrand Factor

Coagulation Factor Concentrates Segment by Application

Pulmonology

Rheumatology

Immunology

Neurology

Hematology

Hemato-Oncology

Critical Care

Others

Coagulation Factor Concentrates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor Concentrates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Coagulation Factor Concentrates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor Concentrates sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coagulation Factor Concentrates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Factor XIII Major Manufacturers Table 3. Factor VIII Major Manufacturers Table 4. Factor IX Major Manufacturers Table 5. Fibrinogen Concentrates Major Manufacturers Table 6. Prothrombin Complex Concentrates Major Manufacturers Table 7. Von Willebrand Factor Major Manufacturers Table 8. Global Coagulation Factor Concentrates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Pulmonology Major Manufacturers Table 10. Rheumatology Major Manufacturers Table 11. Immunology Major Manufacturers Table 12. Neurology Major Manufacturers Table 13. Hematology Major Manufacturers Table 14. Hemato-Oncology Major Manufacturers Table 15. Critical Care Major Manufacturers Table 16. Others Major Manufacturers Table 17. Coagulation Factor Concentrates Industry Trends Table 18. Coagulation Factor Concentrates Industry Drivers Table 19. Coagulation Factor Concentrates Industry Opportunities and Challenges Table 20. Coagulation Factor Concentrates Industry Restraints Table 21. Global Coagulation Factor Concentrates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Coagulation Factor Concentrates Revenue by Region (2021-2026) & (US$ Million) Table 23. Global Coagulation Factor Concentrates Revenue by Region (2027-2032) & (US$ Million) Table 24. Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2026) Table 25. Global Coagulation Factor Concentrates Revenue Market Share by Region (2027-2032) Table 26. Global Coagulation Factor Concentrates Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 27. Global Coagulation Factor Concentrates Sales by Region (2021-2026) & (k units) Table 28. Global Coagulation Factor Concentrates Sales by Region (2027-2032) & (k units) Table 29. Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2026) Table 30. Global Coagulation Factor Concentrates Sales Market Share by Region (2027-2032) Table 31. Global Coagulation Factor Concentrates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2021-2026) Table 33. Global Coagulation Factor Concentrates Sales by Manufacturers (US$ Million) & (2021-2026) Table 34. Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2021-2026) Table 35. Global Coagulation Factor Concentrates Sales Price (US$/unit) of Manufacturers (2021-2026) Table 36. Global Coagulation Factor Concentrates Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 37. Global Coagulation Factor Concentrates Key Manufacturers Manufacturing Sites & Headquarters Table 38. Global Coagulation Factor Concentrates Manufacturers, Product Type & Application Table 39. Global Coagulation Factor Concentrates Manufacturers' Establishment Date Table 40. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 41. Global Coagulation Factor Concentrates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Coagulation Factor Concentrates Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2026) Table 46. Global Coagulation Factor Concentrates Revenue Market Share by Type (2027-2032) Table 47. Global Coagulation Factor Concentrates Sales by Type 2021 VS 2025 VS 2032 (k units) Table 48. Global Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 49. Global Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 50. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2026) Table 51. Global Coagulation Factor Concentrates Sales Market Share by Type (2027-2032) Table 52. Global Coagulation Factor Concentrates Price by Type (2021-2026) & (US$/unit) Table 53. Global Coagulation Factor Concentrates Price by Type (2027-2032) & (US$/unit) Table 54. Global Coagulation Factor Concentrates Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 56. Global Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 57. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2026) Table 58. Global Coagulation Factor Concentrates Revenue Market Share by Application (2027-2032) Table 59. Global Coagulation Factor Concentrates Sales by Application 2021 VS 2025 VS 2032 (k units) Table 60. Global Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 61. Global Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 62. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2026) Table 63. Global Coagulation Factor Concentrates Sales Market Share by Application (2027-2032) Table 64. Global Coagulation Factor Concentrates Price by Application (2021-2026) & (US$/unit) Table 65. Global Coagulation Factor Concentrates Price by Application (2027-2032) & (US$/unit) Table 66. Bio Product Laboratory (UK) Company Information Table 67. Bio Product Laboratory (UK) Business Overview Table 68. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio Table 70. Bio Product Laboratory (UK) Recent Development Table 71. Biotest (Germany) Company Information Table 72. Biotest (Germany) Business Overview Table 73. Biotest (Germany) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Biotest (Germany) Coagulation Factor Concentrates Product Portfolio Table 75. Biotest (Germany) Recent Development Table 76. CSL (Australia) Company Information Table 77. CSL (Australia) Business Overview Table 78. CSL (Australia) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CSL (Australia) Coagulation Factor Concentrates Product Portfolio Table 80. CSL (Australia) Recent Development Table 81. Green Cross Corporation (South Korea) Company Information Table 82. Green Cross Corporation (South Korea) Business Overview Table 83. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio Table 85. Green Cross Corporation (South Korea) Recent Development Table 86. Grifols (Spain) Company Information Table 87. Grifols (Spain) Business Overview Table 88. Grifols (Spain) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Grifols (Spain) Coagulation Factor Concentrates Product Portfolio Table 90. Grifols (Spain) Recent Development Table 91. Japan Blood Products Organization, China Biologic Products (China) Company Information Table 92. Japan Blood Products Organization, China Biologic Products (China) Business Overview Table 93. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio Table 95. Japan Blood Products Organization, China Biologic Products (China) Recent Development Table 96. Kedrion (Italy) Company Information Table 97. Kedrion (Italy) Business Overview Table 98. Kedrion (Italy) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio Table 100. Kedrion (Italy) Recent Development Table 101. LFB (France) Company Information Table 102. LFB (France) Business Overview Table 103. LFB (France) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. LFB (France) Coagulation Factor Concentrates Product Portfolio Table 105. LFB (France) Recent Development Table 106. Octapharma (Switzerland) Company Information Table 107. Octapharma (Switzerland) Business Overview Table 108. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio Table 110. Octapharma (Switzerland) Recent Development Table 111. Sanquin (Netherlands) Company Information Table 112. Sanquin (Netherlands) Business Overview Table 113. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio Table 115. Sanquin (Netherlands) Recent Development Table 116. Shire (Ireland) Company Information Table 117. Shire (Ireland) Business Overview Table 118. Shire (Ireland) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Shire (Ireland) Coagulation Factor Concentrates Product Portfolio Table 120. Shire (Ireland) Recent Development Table 121. Shanghai RAAS Blood Products (China) Company Information Table 122. Shanghai RAAS Blood Products (China) Business Overview Table 123. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio Table 125. Shanghai RAAS Blood Products (China) Recent Development Table 126. North America Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 129. North America Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 130. North America Coagulation Factor Concentrates Sales Price by Type (2021-2026) & (US$/unit) Table 131. North America Coagulation Factor Concentrates Sales Price by Type (2027-2032) & (US$/unit) Table 132. North America Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 135. North America Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 136. North America Coagulation Factor Concentrates Sales Price by Application (2021-2026) & (US$/unit) Table 137. North America Coagulation Factor Concentrates Sales Price by Application (2027-2032) & (US$/unit) Table 138. North America Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Coagulation Factor Concentrates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Coagulation Factor Concentrates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. North America Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 143. North America Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 144. North America Coagulation Factor Concentrates Sales Price by Country (2021-2026) & (US$/unit) Table 145. North America Coagulation Factor Concentrates Sales Price by Country (2027-2032) & (US$/unit) Table 146. United States Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 147. Canada Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 148. Mexico Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 149. Europe Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 152. Europe Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 153. Europe Coagulation Factor Concentrates Sales Price by Type (2021-2026) & (US$/unit) Table 154. Europe Coagulation Factor Concentrates Sales Price by Type (2027-2032) & (US$/unit) Table 155. Europe Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 158. Europe Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 159. Europe Coagulation Factor Concentrates Sales Price by Application (2021-2026) & (US$/unit) Table 160. Europe Coagulation Factor Concentrates Sales Price by Application (2027-2032) & (US$/unit) Table 161. Europe Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Coagulation Factor Concentrates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Coagulation Factor Concentrates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 165. Europe Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 166. Europe Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 167. Europe Coagulation Factor Concentrates Sales Price by Country (2021-2026) & (US$/unit) Table 168. Europe Coagulation Factor Concentrates Sales Price by Country (2027-2032) & (US$/unit) Table 169. Germany Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 170. France Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 171. U.K. Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 172. Italy Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 173. Russia Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 174. Spain Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 177. Sweden Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 178. Poland Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 179. China Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 180. China Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 181. China Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 182. China Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 183. China Coagulation Factor Concentrates Sales Price by Type (2021-2026) & (US$/unit) Table 184. China Coagulation Factor Concentrates Sales Price by Type (2027-2032) & (US$/unit) Table 185. China Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 186. China Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 187. China Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 188. China Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 189. China Coagulation Factor Concentrates Sales Price by Application (2021-2026) & (US$/unit) Table 190. China Coagulation Factor Concentrates Sales Price by Application (2027-2032) & (US$/unit) Table 191. Asia Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 194. Asia Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 195. Asia Coagulation Factor Concentrates Sales Price by Type (2021-2026) & (US$/unit) Table 196. Asia Coagulation Factor Concentrates Sales Price by Type (2027-2032) & (US$/unit) Table 197. Asia Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 200. Asia Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 201. Asia Coagulation Factor Concentrates Sales Price by Application (2021-2026) & (US$/unit) Table 202. Asia Coagulation Factor Concentrates Sales Price by Application (2027-2032) & (US$/unit) Table 203. Asia Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Coagulation Factor Concentrates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Coagulation Factor Concentrates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 207. Asia Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 208. Asia Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 209. Asia Coagulation Factor Concentrates Sales Price by Country (2021-2026) & (US$/unit) Table 210. Asia Coagulation Factor Concentrates Sales Price by Country (2027-2032) & (US$/unit) Table 211. Japan Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 212. South Korea Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 213. India Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 214. Australia Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 220. SAMEA Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 221. SAMEA Coagulation Factor Concentrates Sales Price by Type (2021-2026) & (US$/unit) Table 222. SAMEA Coagulation Factor Concentrates Sales Price by Type (2027-2032) & (US$/unit) Table 223. SAMEA Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 226. SAMEA Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 227. SAMEA Coagulation Factor Concentrates Sales Price by Application (2021-2026) & (US$/unit) Table 228. SAMEA Coagulation Factor Concentrates Sales Price by Application (2027-2032) & (US$/unit) Table 229. SAMEA Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Coagulation Factor Concentrates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Coagulation Factor Concentrates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 233. SAMEA Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 234. SAMEA Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 235. SAMEA Coagulation Factor Concentrates Sales Price by Country (2021-2026) & (US$/unit) Table 236. SAMEA Coagulation Factor Concentrates Sales Price by Country (2027-2032) & (US$/unit) Table 237. Brazil Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 238. Argentina Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 239. Chile Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 240. Colombia Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 241. Peru Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 243. Israel Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 244. UAE Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 245. Turkey Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 246. Iran Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 247. Egypt Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Coagulation Factor Concentrates Distributors List Table 251. Coagulation Factor Concentrates Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Coagulation Factor Concentrates Image Figure 2. Global Coagulation Factor Concentrates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor Concentrates Market Size Share 2021 VS 2025 VS 2032 Figure 4. Factor XIII Image Figure 5. Factor VIII Image Figure 6. Factor IX Image Figure 7. Fibrinogen Concentrates Image Figure 8. Prothrombin Complex Concentrates Image Figure 9. Von Willebrand Factor Image Figure 10. Global Coagulation Factor Concentrates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Coagulation Factor Concentrates Market Size Share 2021 VS 2025 VS 2032 Figure 12. Pulmonology Image Figure 13. Rheumatology Image Figure 14. Immunology Image Figure 15. Neurology Image Figure 16. Hematology Image Figure 17. Hemato-Oncology Image Figure 18. Critical Care Image Figure 19. Others Image Figure 20. Global Coagulation Factor Concentrates Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Coagulation Factor Concentrates Revenue (2021-2032) & (US$ Million) Figure 22. Global Coagulation Factor Concentrates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Coagulation Factor Concentrates Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2032) Figure 25. Global Coagulation Factor Concentrates Sales (2021-2032) & (k units) Figure 26. Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2032) Figure 28. US & Canada & Mexico Coagulation Factor Concentrates Sales YoY (2021-2032) & (k units) Figure 29. Europe Coagulation Factor Concentrates Sales YoY (2021-2032) & (k units) Figure 30. China Coagulation Factor Concentrates Sales YoY (2021-2032) & (k units) Figure 31. Asia (Excluding China) Coagulation Factor Concentrates Sales YoY (2021-2032) & (k units) Figure 32. South America, Middle East and Africa Coagulation Factor Concentrates Sales YoY (2021-2032) & (k units) Figure 33. Global Coagulation Factor Concentrates Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global Coagulation Factor Concentrates Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global Coagulation Factor Concentrates Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Coagulation Factor Concentrates Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032) Figure 39. Global Coagulation Factor Concentrates Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Coagulation Factor Concentrates Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 41. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032) Figure 42. Global Coagulation Factor Concentrates Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 43. Global Coagulation Factor Concentrates Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032) Figure 45. Global Coagulation Factor Concentrates Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 46. Global Coagulation Factor Concentrates Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 47. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032) Figure 48. North America Coagulation Factor Concentrates Revenue Share by Type (2021-2032) Figure 49. North America Coagulation Factor Concentrates Sales Share by Type (2021-2032) Figure 50. North America Coagulation Factor Concentrates Revenue Share by Application (2021-2032) Figure 51. North America Coagulation Factor Concentrates Sales Share by Application (2021-2032) Figure 52. North America Coagulation Factor Concentrates Revenue Share by Country (2021-2032) Figure 53. North America Coagulation Factor Concentrates Sales Share by Country (2021-2032) Figure 54. Europe Coagulation Factor Concentrates Revenue Share by Type (2021-2032) Figure 55. Europe Coagulation Factor Concentrates Sales Share by Type (2021-2032) Figure 56. Europe Coagulation Factor Concentrates Revenue Share by Application (2021-2032) Figure 57. Europe Coagulation Factor Concentrates Sales Share by Application (2021-2032) Figure 58. Europe Coagulation Factor Concentrates Revenue Share by Country (2021-2032) Figure 59. Europe Coagulation Factor Concentrates Sales Share by Country (2021-2032) Figure 60. China Coagulation Factor Concentrates Revenue Share by Type (2021-2032) Figure 61. China Coagulation Factor Concentrates Sales Share by Type (2021-2032) Figure 62. China Coagulation Factor Concentrates Revenue Share by Application (2021-2032) Figure 63. China Coagulation Factor Concentrates Sales Share by Application (2021-2032) Figure 64. Asia Coagulation Factor Concentrates Revenue Share by Type (2021-2032) Figure 65. Asia Coagulation Factor Concentrates Sales Share by Type (2021-2032) Figure 66. Asia Coagulation Factor Concentrates Revenue Share by Application (2021-2032) Figure 67. Asia Coagulation Factor Concentrates Sales Share by Application (2021-2032) Figure 68. Asia Coagulation Factor Concentrates Revenue Share by Country (2021-2032) Figure 69. Asia Coagulation Factor Concentrates Sales Share by Country (2021-2032) Figure 70. SAMEA Coagulation Factor Concentrates Revenue Share by Type (2021-2032) Figure 71. SAMEA Coagulation Factor Concentrates Sales Share by Type (2021-2032) Figure 72. SAMEA Coagulation Factor Concentrates Revenue Share by Application (2021-2032) Figure 73. SAMEA Coagulation Factor Concentrates Sales Share by Application (2021-2032) Figure 74. SAMEA Coagulation Factor Concentrates Revenue Share by Country (2021-2032) Figure 75. SAMEA Coagulation Factor Concentrates Sales Share by Country (2021-2032) Figure 76. Coagulation Factor Concentrates Value Chain Figure 77. Manufacturing Cost Structure Figure 78. Coagulation Factor Concentrates Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Factor XIII
  • Factor VIII
  • Factor IX
  • Fibrinogen Concentrates
  • Prothrombin Complex Concentrates
  • Von Willebrand Factor
Applications
  • Pulmonology
  • Rheumatology
  • Immunology
  • Neurology
  • Hematology
  • Hemato-Oncology
  • Critical Care
  • Others
Companies covered
  • Bio Product Laboratory (UK)
  • Biotest (Germany)
  • CSL (Australia)
  • Green Cross Corporation (South Korea)
  • Grifols (Spain)
  • Japan Blood Products Organization, China Biologic Products (China)
  • Kedrion (Italy)
  • LFB (France)
  • Octapharma (Switzerland)
  • Sanquin (Netherlands)
  • Shire (Ireland)
  • Shanghai RAAS Blood Products (China)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coagulation Factor Concentrates Market by Type
  3. 1.2.1 Global Coagulation Factor Concentrates Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Factor XIII
  5. 1.2.3 Factor VIII
  6. 1.2.4 Factor IX
  7. 1.2.5 Fibrinogen Concentrates
  8. 1.2.6 Prothrombin Complex Concentrates
  9. 1.2.7 Von Willebrand Factor
  10. 1.3 Coagulation Factor Concentrates Market by Application
  11. 1.3.1 Global Coagulation Factor Concentrates Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Pulmonology
  13. 1.3.3 Rheumatology
  14. 1.3.4 Immunology
  15. 1.3.5 Neurology
  16. 1.3.6 Hematology
  17. 1.3.7 Hemato-Oncology
  18. 1.3.8 Critical Care
  19. 1.3.9 Others
  20. 1.4 Assumptions and Limitations
  21. 1.5 Study Goals and Objectives
2 Coagulation Factor Concentrates Market Dynamics
  1. 2.1 Coagulation Factor Concentrates Industry Trends
  2. 2.2 Coagulation Factor Concentrates Industry Drivers
  3. 2.3 Coagulation Factor Concentrates Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor Concentrates Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Coagulation Factor Concentrates Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Coagulation Factor Concentrates Revenue by Region
  3. 3.2.1 Global Coagulation Factor Concentrates Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coagulation Factor Concentrates Revenue by Region (2021-2026)
  5. 3.2.3 Global Coagulation Factor Concentrates Revenue by Region (2027-2032)
  6. 3.2.4 Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Coagulation Factor Concentrates Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Coagulation Factor Concentrates Sales by Region
  9. 3.4.1 Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Coagulation Factor Concentrates Sales by Region (2021-2026)
  11. 3.4.3 Global Coagulation Factor Concentrates Sales by Region (2027-2032)
  12. 3.4.4 Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Coagulation Factor Concentrates Revenue by Manufacturers
  2. 4.1.1 Global Coagulation Factor Concentrates Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Coagulation Factor Concentrates Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coagulation Factor Concentrates Sales by Manufacturers
  6. 4.2.1 Global Coagulation Factor Concentrates Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Coagulation Factor Concentrates Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Coagulation Factor Concentrates Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Coagulation Factor Concentrates Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Coagulation Factor Concentrates Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Coagulation Factor Concentrates Manufacturers, Product Type & Application
  13. 4.7 Global Coagulation Factor Concentrates Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Coagulation Factor Concentrates Market CR5 and HHI
  16. 4.8.2 2025 Coagulation Factor Concentrates Tier 1, Tier 2, and Tier 3
5 Coagulation Factor Concentrates Market by Type
  1. 5.1 Global Coagulation Factor Concentrates Revenue by Type
  2. 5.1.1 Global Coagulation Factor Concentrates Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Coagulation Factor Concentrates Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Coagulation Factor Concentrates Sales by Type
  6. 5.2.1 Global Coagulation Factor Concentrates Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coagulation Factor Concentrates Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032)
  9. 5.3 Global Coagulation Factor Concentrates Price by Type
6 Coagulation Factor Concentrates Market by Application
  1. 6.1 Global Coagulation Factor Concentrates Revenue by Application
  2. 6.1.1 Global Coagulation Factor Concentrates Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Coagulation Factor Concentrates Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Coagulation Factor Concentrates Sales by Application
  6. 6.2.1 Global Coagulation Factor Concentrates Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Coagulation Factor Concentrates Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032)
  9. 6.3 Global Coagulation Factor Concentrates Price by Application
7 Company Profiles
  1. 7.1 Bio Product Laboratory (UK)
  2. 7.1.1 Bio Product Laboratory (UK) Company Information
  3. 7.1.2 Bio Product Laboratory (UK) Business Overview
  4. 7.1.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
  6. 7.1.5 Bio Product Laboratory (UK) Recent Developments
  7. 7.2 Biotest (Germany)
  8. 7.2.1 Biotest (Germany) Company Information
  9. 7.2.2 Biotest (Germany) Business Overview
  10. 7.2.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
  12. 7.2.5 Biotest (Germany) Recent Developments
  13. 7.3 CSL (Australia)
  14. 7.3.1 CSL (Australia) Company Information
  15. 7.3.2 CSL (Australia) Business Overview
  16. 7.3.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
  18. 7.3.5 CSL (Australia) Recent Developments
  19. 7.4 Green Cross Corporation (South Korea)
  20. 7.4.1 Green Cross Corporation (South Korea) Company Information
  21. 7.4.2 Green Cross Corporation (South Korea) Business Overview
  22. 7.4.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
  24. 7.4.5 Green Cross Corporation (South Korea) Recent Developments
  25. 7.5 Grifols (Spain)
  26. 7.5.1 Grifols (Spain) Company Information
  27. 7.5.2 Grifols (Spain) Business Overview
  28. 7.5.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
  30. 7.5.5 Grifols (Spain) Recent Developments
  31. 7.6 Japan Blood Products Organization, China Biologic Products (China)
  32. 7.6.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
  33. 7.6.2 Japan Blood Products Organization, China Biologic Products (China) Business Overview
  34. 7.6.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
  36. 7.6.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments
  37. 7.7 Kedrion (Italy)
  38. 7.7.1 Kedrion (Italy) Company Information
  39. 7.7.2 Kedrion (Italy) Business Overview
  40. 7.7.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
  42. 7.7.5 Kedrion (Italy) Recent Developments
  43. 7.8 LFB (France)
  44. 7.8.1 LFB (France) Company Information
  45. 7.8.2 LFB (France) Business Overview
  46. 7.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
  48. 7.8.5 LFB (France) Recent Developments
  49. 7.9 Octapharma (Switzerland)
  50. 7.9.1 Octapharma (Switzerland) Company Information
  51. 7.9.2 Octapharma (Switzerland) Business Overview
  52. 7.9.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
  54. 7.9.5 Octapharma (Switzerland) Recent Developments
  55. 7.10 Sanquin (Netherlands)
  56. 7.10.1 Sanquin (Netherlands) Company Information
  57. 7.10.2 Sanquin (Netherlands) Business Overview
  58. 7.10.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
  60. 7.10.5 Sanquin (Netherlands) Recent Developments
  61. 7.11 Shire (Ireland)
  62. 7.11.1 Shire (Ireland) Company Information
  63. 7.11.2 Shire (Ireland) Business Overview
  64. 7.11.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
  66. 7.11.5 Shire (Ireland) Recent Developments
  67. 7.12 Shanghai RAAS Blood Products (China)
  68. 7.12.1 Shanghai RAAS Blood Products (China) Company Information
  69. 7.12.2 Shanghai RAAS Blood Products (China) Business Overview
  70. 7.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
  72. 7.12.5 Shanghai RAAS Blood Products (China) Recent Developments
8 North America
  1. 8.1 North America Coagulation Factor Concentrates Market Size by Type
  2. 8.1.1 North America Coagulation Factor Concentrates Revenue by Type (2021-2032)
  3. 8.1.2 North America Coagulation Factor Concentrates Sales by Type (2021-2032)
  4. 8.1.3 North America Coagulation Factor Concentrates Price by Type (2021-2032)
  5. 8.2 North America Coagulation Factor Concentrates Market Size by Application
  6. 8.2.1 North America Coagulation Factor Concentrates Revenue by Application (2021-2032)
  7. 8.2.2 North America Coagulation Factor Concentrates Sales by Application (2021-2032)
  8. 8.2.3 North America Coagulation Factor Concentrates Price by Application (2021-2032)
  9. 8.3 North America Coagulation Factor Concentrates Market Size by Country
  10. 8.3.1 North America Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Coagulation Factor Concentrates Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Coagulation Factor Concentrates Market Size by Type
  2. 9.1.1 Europe Coagulation Factor Concentrates Revenue by Type (2021-2032)
  3. 9.1.2 Europe Coagulation Factor Concentrates Sales by Type (2021-2032)
  4. 9.1.3 Europe Coagulation Factor Concentrates Price by Type (2021-2032)
  5. 9.2 Europe Coagulation Factor Concentrates Market Size by Application
  6. 9.2.1 Europe Coagulation Factor Concentrates Revenue by Application (2021-2032)
  7. 9.2.2 Europe Coagulation Factor Concentrates Sales by Application (2021-2032)
  8. 9.2.3 Europe Coagulation Factor Concentrates Price by Application (2021-2032)
  9. 9.3 Europe Coagulation Factor Concentrates Market Size by Country
  10. 9.3.1 Europe Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Coagulation Factor Concentrates Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Coagulation Factor Concentrates Market Size by Type
  2. 10.1.1 China Coagulation Factor Concentrates Revenue by Type (2021-2032)
  3. 10.1.2 China Coagulation Factor Concentrates Sales by Type (2021-2032)
  4. 10.1.3 China Coagulation Factor Concentrates Price by Type (2021-2032)
  5. 10.2 China Coagulation Factor Concentrates Market Size by Application
  6. 10.2.1 China Coagulation Factor Concentrates Revenue by Application (2021-2032)
  7. 10.2.2 China Coagulation Factor Concentrates Sales by Application (2021-2032)
  8. 10.2.3 China Coagulation Factor Concentrates Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coagulation Factor Concentrates Market Size by Type
  2. 11.1.1 Asia Coagulation Factor Concentrates Revenue by Type (2021-2032)
  3. 11.1.2 Asia Coagulation Factor Concentrates Sales by Type (2021-2032)
  4. 11.1.3 Asia Coagulation Factor Concentrates Price by Type (2021-2032)
  5. 11.2 Asia Coagulation Factor Concentrates Market Size by Application
  6. 11.2.1 Asia Coagulation Factor Concentrates Revenue by Application (2021-2032)
  7. 11.2.2 Asia Coagulation Factor Concentrates Sales by Application (2021-2032)
  8. 11.2.3 Asia Coagulation Factor Concentrates Price by Application (2021-2032)
  9. 11.3 Asia Coagulation Factor Concentrates Market Size by Country
  10. 11.3.1 Asia Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Coagulation Factor Concentrates Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coagulation Factor Concentrates Market Size by Type
  2. 12.1.1 SAMEA Coagulation Factor Concentrates Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Coagulation Factor Concentrates Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Coagulation Factor Concentrates Price by Type (2021-2032)
  5. 12.2 SAMEA Coagulation Factor Concentrates Market Size by Application
  6. 12.2.1 SAMEA Coagulation Factor Concentrates Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Coagulation Factor Concentrates Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Coagulation Factor Concentrates Price by Application (2021-2032)
  9. 12.3 SAMEA Coagulation Factor Concentrates Market Size by Country
  10. 12.3.1 SAMEA Coagulation Factor Concentrates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Coagulation Factor Concentrates Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Coagulation Factor Concentrates Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Coagulation Factor Concentrates Value Chain Analysis
  2. 13.1.1 Coagulation Factor Concentrates Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Coagulation Factor Concentrates Production Mode & Process
  6. 13.2 Coagulation Factor Concentrates Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Coagulation Factor Concentrates Distributors
  9. 13.2.3 Coagulation Factor Concentrates Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst